Oriola-KD Corporation Stock Exchange Release 9 May 2012 at 1:45 p.m.
Oriola-KD's Swedish pharmaceutical wholesale business, Oriola AB has signed a letter of intent with Apoteksgruppen, DocMorris, Medstop and Vårdapoteket on purchasing, warehousing and pharmacy distribution of OTC and traded goods products. The pharmacy chains signing the letter of intent had a combined market share of some 25 percent of the Swedish pharmacy market in 2011.(KPMG report 01/2012)
The target is to sign co-operation agreements with the pharmacy chains during the second quarter and to start the co-operation in the autumn of 2012.
"The letter of intent with Apoteksgruppen, DocMorris, Medstop and Vårdapoteket on purchasing, warehousing and pharmacy distribution of OTC products and traded goods is a significant strategic step for Oriola-KD. We are extremely pleased with the upcoming co-operation with these pharmacy chains. We will continue our determined work for providing and developing high quality services for pharmaceutical companies and pharmacies in Sweden." Eero Hautaniemi, President & CEO, Oriola-KD Corporation.
Oriola-KD Corporation
Eero Hautaniemi
President & CEO
For additional information, please contact:
Mr. Eero Hautaniemi
President & CEO
tel. +358 10 429 2109
email: eero.hautaniemi@oriola-kd.com
Distribution:
NASDAQ OMX Helsinki Ltd.
Principal media
Published by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo
www.oriola-kd.com
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Oriola-KD Oyj via Thomson Reuters ONE
